Hao Guo - Concepedia

Author

Hao Guo

Dana-Farber Cancer Institute ORCID

Also Known As

Guo Hao, Guo, Hao, H Guo, H. Guo, Hao Guo, Ian Krop, Krop, Ian

103

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Massachusetts General Hospital Brigham and Women's Hospital Memorial Sloan Kettering Cancer Center Harvard University

About

Hao Guo is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.2K
2	Health Sciences	4	4	310
3	Public Health	1	1	17
4	Biology	1	1	42
5	Cell Biology	1	1	230

Hao Guo

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer Sara M. Tolaney, William T. Barry, Chau T. Dang, New England Journal of Medicine	2015	731
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer Shaokun Shu, Charles Y. Lin, Housheng Hansen He, Nature Breast OncologyMedicineImmunologyPharmacologyBreast Cancer	2016	616
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Sara M. Tolaney, Hao Guo, Sònia Pernas, Journal of Clinical Oncology	2019	276
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer Daniel G. Stover, Heather A. Parsons, Gavin Ha, Journal of Clinical Oncology Radiation OncologyBreast OncologySomatic VariantTumor HeterogeneityMedicine	2018	230
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer Daniel G. Stover, Carlos R. Gil Del Alcazar, Jane Brock, npj Breast Cancer	2018	142
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer Ana C. Garrido-Castro, Cristina Saura, Romualdo Barroso‐Sousa, Breast Cancer Research	2020	141
Glutathione Peroxidase Enzyme Activity in Aging Sara Espinoza, Hao Guo, Neal S. Fedarko, The Journals of Gerontology Series A	2008	132
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients Sara M. Tolaney, David R. Ziehr, Hao Guo, The Oncologist	2016	110
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer Chau T. Dang, Hao Guo, Julie Najita, JAMA Oncology	2015	91
Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial) Kathryn J. Ruddy, Hao Guo, William T. Barry, Breast Cancer Research and Treatment OncologyApt TrialClinical TrialsPharmacotherapyCancer Treatment	2015	75

Page 1